Correlation Between Conduit Pharmaceuticals and Tango Therapeutics

Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and Tango Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and Tango Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Conduit Pharmaceuticals and Tango Therapeutics, you can compare the effects of market volatilities on Conduit Pharmaceuticals and Tango Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of Tango Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and Tango Therapeutics.

Diversification Opportunities for Conduit Pharmaceuticals and Tango Therapeutics

0.62

Correlation Coefficient

Conduit Pharmaceuticals  Tango Therapeutics

Poor diversification

The 3 months correlation between Conduit and Tango is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and Tango Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tango Therapeutics and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with Tango Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tango Therapeutics has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and Tango Therapeutics go up and down completely randomly.

Pair Corralation between Conduit Pharmaceuticals and Tango Therapeutics

Assuming the 90 days horizon Conduit Pharmaceuticals is expected to under-perform the Tango Therapeutics. In addition to that, Conduit Pharmaceuticals is 5.44 times more volatile than Tango Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Tango Therapeutics is currently generating about -0.23 per unit of volatility. If you would invest  392.00  in Tango Therapeutics on September 23, 2024 and sell it today you would lose (82.00) from holding Tango Therapeutics or give up 20.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	80.95%
Values	Daily Returns

Conduit Pharmaceuticals  vs.  Tango Therapeutics

Conduit Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Conduit Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Conduit Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Tango Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tango Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Conduit Pharmaceuticals and Tango Therapeutics

The main advantage of trading using opposite Conduit Pharmaceuticals and Tango Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, Tango Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tango Therapeutics will offset losses from the drop in Tango Therapeutics' long position.

The idea behind Conduit Pharmaceuticals and Tango Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.